Salacia reticulata for Health & Longevity - Quick Reference Sheet
evipedia.ai ← Back

Salacia reticulata for Health & Longevity

Created on 07/06/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 – Audit

A traditional South Asian plant that slows carbohydrate digestion, softening the blood-sugar rise after a meal. The most consistent evidence shows a real reduction in after-meal blood sugar; signs of lower long-term blood sugar and better cholesterol are modest and uncertain. Small, short, often industry-funded studies limit confidence; the main downsides are digestive. (Full Review)

Protocol

Dose
240–1,000 mg/day
Standardized root/stem extract; ~500 mg/day used in several controlled studies
Timing
With carb meals
Taken immediately before or at the start of a carbohydrate-containing meal
Schedule
Split dosing
One portion with each main meal; each dose only works on the meal it accompanies
Time to effect
Post-meal glucose
Immediate
Present with the first properly timed dose
Long-term glucose
Weeks–months
HbA1c changes over weeks to a few months of consistent use
Blood lipids
Weeks–months
LDL and triglyceride changes over weeks to a few months

Benefits

Contraindications
  • Type 1 diabetes or insulin use
  • Pregnancy or breastfeeding
  • Active inflammatory bowel disease or significant chronic GI disorders
  • Significant liver or kidney impairment
  • Scheduled surgery (stop ≥2 weeks before)
    •
Key Interactions
  • Insulin, sulfonylureas (glibenclamide, glipizide, glimepiride), meglitinides (repaglinide, nateglinide)
  • Other α-glucosidase inhibitors (acarbose, miglitol)
  • Metformin and other oral glucose-lowering agents
  • OTC blood-sugar aids and anti-gas products (simethicone)
  • Glucose-lowering supplements (berberine, Gymnema sylvestre, bitter melon, fenugreek, cinnamon, chromium)
  • High-dose fiber supplements
    •

Risk & Side Effects

  • High: Gastrointestinal side effects
    •
  • Low: Hypoglycemia when combined with glucose-lowering medications
    •
  • Speculative: Unknown long-term safety; theoretical effects on nutrient and mineral absorption
    •

Monitoring

Marker Target Why
Fasting blood glucose 70–85 mg/dL Baseline glucose control and trend
HbA1c ≤ 5.3% Longer-term glucose control
Post-meal (2-hour) glucose < 120 mg/dL Directly tracks the plant's main target — the after-meal spike
Fasting insulin 2–6 µIU/mL Insulin resistance and metabolic reserve
LDL cholesterol < 100 mg/dL (lower if higher risk) Secondary lipid benefit
Triglycerides < 80 mg/dL Carbohydrate-sensitive lipid marker
ALT / AST ALT < 25 (men), < 22 (women) U/L General safety screen for the liver

Cadence: Baseline, again at 4–6 weeks, then every 3–6 months; more frequent home glucose checks in the first weeks for anyone also taking glucose-lowering medication

Qualitative Assessment

  • Digestive tolerance
  • Energy after meals
  • Appetite and satiety
  • Adherence feasibility
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.